RGBP · Regen BioPharma Inc · Investor Relations
$0.00
+0.00 (+0.00%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without additional funding, there is substantial doubt about the Company's ability to continue as a going concern for the twelve months from the date of these financial statements.”View the 10-Q filed Aug 17, 2026
Market Cap
$335,055
Shares
1.68B
Volume · Nov 6
3.62M
Avg daily vol (3M)
7.96M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
No Investor Relations Content
No press releases or events have been collected for this stock yet.